Aclaris Therapeutics Inc. Stock Price (ACRS)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

Omega Healthcare maintained as hold with $32 price target at SunTrust Robinson HumphreyThu, 2 Jul 2020 07:05:30 UTC via MarketWatch
Tabula Rasa HealthCare initiated as buy at SunTrust Robinson HumphreyThu, 2 Jul 2020 06:57:54 UTC via MarketWatch
Akero Therapeutics (AKRO) Reports Biopsy Data and Safety/Tolerability for 16-Week Phase 2a Study in NASH Patients - SlideshowWed, 1 Jul 2020 18:13:35 UTC via Seeking Alpha
Tap the Future of Healthcare With This Hot ETFWed, 1 Jul 2020 14:14:21 UTC via ETF Trends
Halozyme Therapeutics started at buy with $39 stock price target at BenchmarkWed, 1 Jul 2020 07:08:56 UTC via MarketWatch
Molina Healthcare started at outperform with $220 stock price target at SVB LeerinkWed, 1 Jul 2020 06:49:26 UTC via MarketWatch
Relay Therapeutics Starts IPO ProcessTue, 30 Jun 2020 16:37:03 UTC via Seeking Alpha
Why Prestige Consumer Healthcare Is Struggling In The New COVID-19 E-Commerce Centric WorldTue, 30 Jun 2020 14:40:00 UTC via Seeking Alpha
Fisher & Paykel Healthcare Corporation Limited (FSPKF) CEO Lewis Gradon on Q4 2020 Results - Earnings Call TranscriptMon, 29 Jun 2020 16:40:08 UTC via Seeking Alpha
Prestige Consumer Healthcare upgraded to buy from neutral at Sidoti & Co.Mon, 29 Jun 2020 12:36:29 UTC via MarketWatch

Aclaris Therapeutics Inc. Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:ACRS

You don't have any alerts set for IEX:ACRS.

About Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.

CEONeal Walker IndustryBiotechnology SectorHealthcare Websitehttp://www.aclaristx.com Issue ExchangeNasdaq Global Select Issue TypeUnknown

Real-time ACRS to USD Trade Analysis on IEX

Market Status Premarket

Analysis is available when the exchange & market are open.